|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1999-6-4
|
|
pubmed:abstractText |
The nuclear protein B23, nucleophosmin, is an RNA-associated nucleolar phosphoprotein reported to be more abundant in malignant and growing cells than in normal nondividing cells. We examined the levels of B23 in fresh human prostate tissue and in five human prostate cancer cell lines with monoclonal antibodies (mAb) to nucleophosmin (alpha-B23) and to human prostate cancer nuclear matrix proteins (PRO:4-216).
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0270-4137
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
39
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
298-304
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:10344220-Antibodies, Monoclonal,
pubmed-meshheading:10344220-Antigens, Nuclear,
pubmed-meshheading:10344220-Autoantigens,
pubmed-meshheading:10344220-Blotting, Western,
pubmed-meshheading:10344220-DNA-Binding Proteins,
pubmed-meshheading:10344220-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:10344220-Humans,
pubmed-meshheading:10344220-Immunohistochemistry,
pubmed-meshheading:10344220-Male,
pubmed-meshheading:10344220-Nuclear Proteins,
pubmed-meshheading:10344220-Prostatic Neoplasms,
pubmed-meshheading:10344220-Tumor Cells, Cultured,
pubmed-meshheading:10344220-Tumor Markers, Biological
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23.
|
|
pubmed:affiliation |
Department of Urology, Johns Hopkins Hospital, Baltimore, Maryland 21287-2101, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
